84 related articles for article (PubMed ID: 9579736)
1. Enhanced involvement of endothelin in the haemodynamic sequelae of endotoxaemia in conscious, hypertensive, transgenic ((mRen-2)27) rats.
Gardiner SM; Kemp PA; March JE; Bennett T
Br J Pharmacol; 1998 Apr; 123(7):1403-8. PubMed ID: 9579736
[TBL] [Abstract][Full Text] [Related]
2. The influence of antibodies to TNF-alpha and IL-1beta on haemodynamic responses to the cytokines, and to lipopolysaccharide, in conscious rats.
Gardiner SM; Kemp PA; March JE; Woolley J; Bennett T
Br J Pharmacol; 1998 Dec; 125(7):1543-50. PubMed ID: 9884083
[TBL] [Abstract][Full Text] [Related]
3. Haemodynamic effects of losartan and the endothelin antagonist, SB 209670, in conscious, transgenic ((mRen-2)27), hypertensive rats.
Gardiner SM; March JE; Kemp PA; Mullins JJ; Bennett T
Br J Pharmacol; 1995 Oct; 116(4):2237-44. PubMed ID: 8564254
[TBL] [Abstract][Full Text] [Related]
4. Temporal differences between the involvement of angiotensin II and endothelin in the cardiovascular responses to endotoxaemia in conscious rats.
Gardiner SM; Kemp PA; March JE; Bennett T
Br J Pharmacol; 1996 Dec; 119(8):1619-27. PubMed ID: 8982510
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of endotoxaemia on pressor and vasoconstrictor actions of angiotensin II and arginine vasopressin in conscious rats.
Tarpey SB; Bennett T; Randall MD; Gardiner SM
Br J Pharmacol; 1998 Apr; 123(7):1367-74. PubMed ID: 9579732
[TBL] [Abstract][Full Text] [Related]
6. Influence of aminoguanidine and the endothelin antagonist, SB 209670, on the regional haemodynamic effects of endotoxaemia in conscious rats.
Gardiner SM; Kemp PA; March JE; Bennett T
Br J Pharmacol; 1996 Aug; 118(7):1822-8. PubMed ID: 8842449
[TBL] [Abstract][Full Text] [Related]
7. Effects of the dual metallopeptidase inhibitor, MDL 100,240, on regional haemodynamic responses to vasoactive peptides in conscious rats.
Gardiner SM; Kemp PA; Brunner-Ferber F; Bennett T
Br J Pharmacol; 1997 Dec; 122(8):1687-93. PubMed ID: 9422815
[TBL] [Abstract][Full Text] [Related]
8. Effects of the novel selective endothelin ET(A) receptor antagonist, SB 234551, on the cardiovascular responses to endotoxaemia in conscious rats.
Gardiner SM; March JE; Kemp PA; Bennett T
Br J Pharmacol; 2001 Aug; 133(8):1371-7. PubMed ID: 11498524
[TBL] [Abstract][Full Text] [Related]
9. The contribution of nitric oxide to cardiovascular status and responses to vasodilators in conscious, hypertensive, transgenic ((mRen-2)27) rats.
Gardiner SM; March JE; Kemp PA; Bennett T
Br J Pharmacol; 1998 May; 124(2):299-306. PubMed ID: 9641546
[TBL] [Abstract][Full Text] [Related]
10. Regional haemodynamic responses to infusion of lipopolysaccharide in conscious rats: effects of pre- or post-treatment with glibenclamide.
Gardiner SM; Kemp PA; March JE; Bennett T
Br J Pharmacol; 1999 Dec; 128(8):1772-8. PubMed ID: 10588933
[TBL] [Abstract][Full Text] [Related]
11. Regional haemodynamic effects of antagonists of angiotensin II, endothelin and adrenoceptors in conscious, vasopressin-deficient, genetically hypertensive rats.
Gardiner SM; March JE; Kemp PA; Bennett T
Br J Pharmacol; 1996 May; 118(2):325-34. PubMed ID: 8735634
[TBL] [Abstract][Full Text] [Related]
12. Comparative effects of the dual metallopeptidase inhibitor, MDL 100,240 and of enalaprilat on regional and on cardiac haemodynamics in conscious, hypertensive, transgenic ((mRen-2)27) rats.
Gardiner SM; Kemp PA; Brunner-Ferber F; Bennett T
Br J Pharmacol; 1997 Dec; 122(8):1694-701. PubMed ID: 9422816
[TBL] [Abstract][Full Text] [Related]
13. Effects of dexamethasone and SB 209670 on the regional haemodynamic responses to lipopolysaccharide in conscious rats.
Gardiner SM; Kemp PA; March JE; Bennett T
Br J Pharmacol; 1996 May; 118(1):141-9. PubMed ID: 8733587
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of the hypotensive and vasodilator effects of endotoxaemia in conscious rats by the endothelin antagonist, SB 209670.
Gardiner SM; Kemp PA; March JE; Bennett T
Br J Pharmacol; 1995 Sep; 116(2):1718-9. PubMed ID: 8528549
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular responses to angiotensins I and II in normotensive and hypertensive rats; effects of NO synthase inhibition or ET receptor antagonism.
Gardiner SM; March JE; Kemp PA; Bennett T
Br J Pharmacol; 1999 Dec; 128(8):1795-803. PubMed ID: 10588936
[TBL] [Abstract][Full Text] [Related]
16. Haemodynamic effects of human alpha-calcitonin gene-related peptide following administration of endothelin-1 or NG-nitro-L-arginine methyl ester in conscious rats.
Gardiner SM; Compton AM; Kemp PA; Bennett T; Foulkes R; Hughes B
Br J Pharmacol; 1991 May; 103(1):1256-62. PubMed ID: 1878760
[TBL] [Abstract][Full Text] [Related]
17. Regional haemodynamic responses to acetylcholine, methoxamine, salbutamol and bradykinin during lipopolysaccharide infusion in conscious rats.
Waller J; Gardiner SM; Bennett T
Br J Pharmacol; 1994 Aug; 112(4):1057-64. PubMed ID: 7952864
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of the haemodynamic effects of NG-monomethyl-L-arginine by transforming growth factor-beta 1 in conscious, normal, but not endotoxaemic, rats.
Gardiner SM; Kemp PA; March JE; Bennett T
Br J Pharmacol; 1995 Dec; 116(7):3042-8. PubMed ID: 8680741
[TBL] [Abstract][Full Text] [Related]
19. Regional haemodynamic responses to the cannabinoid agonist, WIN 55212-2, in conscious, normotensive rats, and in hypertensive, transgenic rats.
Gardiner SM; March JE; Kemp PA; Bennett T
Br J Pharmacol; 2001 Jun; 133(3):445-53. PubMed ID: 11375262
[TBL] [Abstract][Full Text] [Related]
20. Influence of CGRP (8-37), but not adrenomedullin (22-52), on the haemodynamic responses to lipopolysaccharide in conscious rats.
Gardiner SM; March JE; Kemp PA; Bennett T
Br J Pharmacol; 1999 Aug; 127(7):1611-8. PubMed ID: 10455317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
